logo
Select company
Select metric
$ 0Net Income to Non-Controlling Interests
VS
Market
10
Sector
8
Industry
7
History
-
$ 63.07Close
$ 5.56 - $ 63.92 52-Week Range
Ticker Information

Ticker

QURE

Company Name

UNIQURE NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UNIQURE NV - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

QURE - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UNIQURE NV's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 0.
  • Over the past 5 years, UNIQURE NV's average Net Inc. NCI has been $ 0.
  • The median Net Inc. NCI for UNIQURE NV during this period was $ 0
  • UNIQURE NV reached its highest Net Inc. NCI over the past 5 years at $ 0.
  • The lowest Net Inc. NCI recorded by UNIQURE NV in the same timeframe $ 0

UNIQURE NV's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
NUVB : NUVATION BIO INC $ 0ZBIO : ZENAS BIOPHARMA INC $ 0ABUS : ARBUTUS BIOPHARMA CORP $ 0IMNM : IMMUNOME INC $ 0VIR : VIR BIOTECHNOLOGY INC $ 0TSHA : TAYSHA GENE THERAPIES INC $ 0CAPR : CAPRICOR THERAPEUTICS INC $ 0RLAY : RELAY THERAPEUTICS INC $ 0BCYC : BICYCLE THERAPEUTICS PLC $ 0TNGX : TANGO THERAPEUTICS INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

QURE - Net Income to Non-Controlling Interests, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.09M with a standard deviation of $ 136.42M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.27K
min$ -1.8B
max$ 2.94B
average$ 11.09M
median$ 0
std$ 136.42M